Barclays PLC Spruce Biosciences, Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$1.15 - $3.17 $174 - $481	-152 Reduced 1.99%	7,484 $17,000
Q4 2022 Feb 13, 2023	SELL	$0.99 - $1.43 $3,767 - $5,442	-3,806 Reduced 33.26%	7,636 $8,000
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.23 $1,598 - $2,785	-1,249 Reduced 9.84%	11,442 $20,000
Q1 2022 May 16, 2022	BUY	$1.85 - $4.59 $23,478 - $58,251	12,691 New	12,691 $25,000

16.9M

26.9K

59.3K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $10.8M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.